<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>MBBS Pathology Notes: Infections & Infestations</title>
    <link href="https://fonts.googleapis.com/css2?family=Kalam:wght@300;400;700&display=swap" rel="stylesheet">
    <style>
        :root {
            --neon-yellow: #f4ff40; /* Neon yellowish highlighter */
            --marker-green: #daffb3; /* Natural light green marker */
            --ink-color: #2c2c2c; /* Dark grey/black ink look */
            --paper-white: #ffffff; /* Pure white page */
            --box-bg: #fffef0; /* Subtle warm tint for boxes */
            --border-color: #333;
        }

        * {
            box-sizing: border-box;
        }

        body {
            background-color: #525659; /* Grey background behind the paper */
            font-family: 'Kalam', cursive;
            color: var(--ink-color);
            margin: 0;
            padding: 20px;
            display: flex;
            justify-content: center;
            line-height: 1.6;
            font-size: 18px; /* Readable handwritten size */
        }

        /* A4 Paper Simulation */
        .page-container {
            background-color: var(--paper-white);
            width: 210mm; /* A4 width */
            min-height: 297mm; /* A4 height minimum */
            padding: 25mm; /* Standard margins */
            box-shadow: 0 4px 15px rgba(0,0,0,0.3);
            position: relative;
            margin-bottom: 20px;
        }

        /* Typography */
        h1 {
            font-size: 32px;
            text-align: center;
            text-decoration: underline;
            text-decoration-color: var(--neon-yellow);
            text-decoration-thickness: 5px;
            margin-bottom: 40px;
            color: #000;
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        h2 {
            font-size: 26px;
            border-bottom: 3px solid var(--marker-green);
            padding-bottom: 5px;
            margin-top: 40px;
            color: #1a1a1a;
            display: inline-block;
            width: 100%;
        }

        h3 {
            font-size: 22px;
            font-weight: 700;
            margin-top: 25px;
            color: #333;
            text-decoration: underline;
        }

        h4 {
            font-size: 20px;
            font-weight: 700;
            margin-top: 15px;
            color: #444;
        }

        p {
            margin-bottom: 15px;
            text-align: justify;
        }

        ul, ol {
            margin-bottom: 15px;
            padding-left: 25px;
        }

        li {
            margin-bottom: 8px;
        }

        /* Highlighting Classes */
        .highlight-neon {
            background-color: var(--neon-yellow);
            padding: 2px 5px;
            border-radius: 4px;
            font-weight: bold;
        }

        .highlight-green {
            background-color: var(--marker-green);
            padding: 2px 5px;
            border-radius: 4px;
        }

        strong {
            font-weight: 700;
        }

        /* Hand-drawn Box Style */
        .hand-drawn-box {
            border: 2px solid var(--border-color);
            /* Irregular border radius for hand-drawn effect */
            border-radius: 2px 20px 3px 25px / 25px 3px 20px 2px;
            padding: 20px;
            margin: 25px 0;
            background-color: var(--box-bg); 
            box-shadow: 3px 4px 0px rgba(0,0,0,0.1);
        }

        /* Table Styling */
        table {
            width: 100%;
            border-collapse: separate;
            border-spacing: 0;
            margin: 20px 0;
            font-size: 16px;
            border: 2px solid var(--border-color);
            border-radius: 8px;
            overflow: hidden;
        }

        th, td {
            border-right: 1px solid var(--border-color);
            border-bottom: 1px solid var(--border-color);
            padding: 12px;
            text-align: left;
            vertical-align: top;
        }

        th {
            background-color: var(--marker-green);
            font-weight: bold;
            border-bottom: 2px solid var(--border-color);
        }

        tr:last-child td {
            border-bottom: none;
        }
        
        tr td:last-child, tr th:last-child {
            border-right: none;
        }

        /* Model Answer Section */
        .qa-section {
            border-left: 4px solid var(--neon-yellow);
            padding-left: 20px;
            margin-top: 30px;
        }

        /* Print Settings */
        @media print {
            body {
                background-color: white;
                padding: 0;
            }
            .page-container {
                width: 100%;
                box-shadow: none;
                margin: 0;
                padding: 15mm;
            }
            /* Ensure background colors print */
            * {
                -webkit-print-color-adjust: exact !important;
                print-color-adjust: exact !important;
            }
            h1, h2, h3 {
                page-break-after: avoid;
            }
            table, .hand-drawn-box, li {
                page-break-inside: avoid;
            }
        }

        /* Responsive Mobile */
        @media (max-width: 800px) {
            .page-container {
                width: 100%;
                padding: 15px;
            }
            table {
                font-size: 14px;
                display: block;
                overflow-x: auto;
            }
        }
    </style>
</head>
<body>

<div class="page-container">

    <h1>TOPIC 9: INFECTIONS AND INFESTATIONS</h1>

    <p><strong>Syllabus Scope:</strong> Pathogenesis and Pathology of Malaria and Leprosy.</p>

    <h2>1. MALARIA</h2>

    <p><strong>Definition:</strong> Malaria is a life-threatening protozoal disease transmitted by the bite of an infected female <em>Anopheles</em> mosquito. It is characterized clinically by cyclic high-grade fever (febrile paroxysms), chills, anemia, and splenomegaly.</p>

    <h3>Etiology</h3>
    <ul>
        <li><strong>Causative Agents (Genus Plasmodium):</strong>
            <ul>
                <li><em>P. vivax:</em> Benign Tertian (Most common in India).</li>
                <li><em>P. falciparum:</em> <span class="highlight-neon">Malignant Tertian</span> (Most severe/fatal).</li>
                <li><em>P. malariae:</em> Quartan.</li>
                <li><em>P. ovale:</em> Benign Tertian.</li>
            </ul>
        </li>
        <li><strong>Vector:</strong> Female <em>Anopheles</em> Mosquito (Definitive Host - Sexual cycle occurs here).</li>
        <li><strong>Human Host:</strong> Intermediate Host (Asexual cycle occurs here).</li>
    </ul>

    <div class="hand-drawn-box">
        <h3>Life Cycle (Brief Overview)</h3>
        <p><strong>1. Exo-erythrocytic (Hepatic) Schizogony:</strong></p>
        <p>Sporozoites injected by mosquito &rarr; Enter Hepatocytes &rarr; Multiply asexually &rarr; Form Hepatic Schizonts &rarr; Rupture &rarr; Release Merozoites.</p>
        <p><em>*Note: P. vivax and P. ovale have dormant forms called <span class="highlight-green">Hypnozoites</span> which cause Relapse.</em></p>

        <p><strong>2. Erythrocytic Schizogony (Blood Stage):</strong></p>
        <p>Merozoites invade RBCs &rarr; Trophozoite (Ring form) &rarr; Erythrocytic Schizont &rarr; Rupture RBCs &rarr; Release Merozoites + Pigment + Toxins &rarr; <span class="highlight-neon">Clinical Fever (Rigors)</span>.</p>
    </div>

    <h3>Pathogenesis</h3>
    <p>The pathology is primarily due to the destruction of Red Blood Cells (RBCs) and the host immune response.</p>

    <h4>1. Anemia (Hemolysis)</h4>
    <ul>
        <li><strong>Direct Hemolysis:</strong> Parasites rupture infected RBCs.</li>
        <li><strong>Splenic Sequestration:</strong> The spleen destroys both infected and uninfected RBCs (which are coated with complement/antibodies).</li>
        <li><strong>Bone Marrow Suppression:</strong> TNF-&alpha; inhibits erythropoiesis.</li>
    </ul>

    <h4>2. Cytoadherence and Sequestration (Specific to P. falciparum)</h4>
    <ul>
        <li><em>P. falciparum</em> infected RBCs develop "knobs" on their surface containing parasite-derived proteins like <span class="highlight-green">PfEMP1</span> (P. falciparum Erythrocyte Membrane Protein 1).</li>
        <li>These knobs bind to adhesion molecules on endothelial cells (e.g., <span class="highlight-neon">ICAM-1, CD36</span>) in small vessels of the brain, kidneys, and lungs.</li>
        <li><strong>Consequences:</strong>
            <ul>
                <li><strong>Sequestration:</strong> Parasitized cells stick to vessel walls and disappear from peripheral blood.</li>
                <li><strong>Rosetting:</strong> Infected RBCs stick to uninfected RBCs, forming clumps.</li>
                <li><strong>Blockage:</strong> Microcirculation is blocked, leading to tissue ischemia and hypoxia (e.g., Cerebral Malaria).</li>
            </ul>
        </li>
    </ul>

    <h4>3. Host Resistance Factors (Genetic Protection)</h4>
    <p>Certain genetic traits provide resistance against malaria:</p>
    <ul>
        <li><strong>Sickle Cell Trait (HbAS):</strong> Heterozygotes are protected against severe <em>P. falciparum</em> malaria. (Parasite cannot thrive in HbS cells; early clearance by spleen).</li>
        <li><strong>Duffy Antigen Negative:</strong> Resistance to <em>P. vivax</em> (Duffy antigen is the entry receptor for P. vivax). Common in West Africa.</li>
        <li><strong>G6PD Deficiency:</strong> Protects against severe malaria.</li>
    </ul>

    <hr>

    <h3>Pathology (Morphology) of Organs</h3>

    <div class="hand-drawn-box">
        <h4>1. Spleen (Splenomegaly)</h4>
        <p><strong>Acute Malaria:</strong></p>
        <ul>
            <li><strong>Gross:</strong> Moderately enlarged (200-500g), soft, hyperemic. Cut surface is dark red or <span class="highlight-neon">Slate-Grey</span>.</li>
            <li><strong>Microscopy:</strong>
                <ul>
                    <li>Congestion of red pulp sinusoids.</li>
                    <li>Macrophages laden with Malarial Pigment (<span class="highlight-green">Hemozoin</span>).</li>
                    <li>Parasitized RBCs may be seen.</li>
                </ul>
            </li>
        </ul>
        <p><strong>Chronic Malaria ("Ague Cake Spleen"):</strong></p>
        <ul>
            <li><strong>Gross:</strong> Massive enlargement (>1000g), firm and hard. Capsule is thickened. Cut surface is grey/black.</li>
            <li><strong>Microscopy:</strong> Fibrosis of red pulp, scarring, and heavy pigment deposition.</li>
        </ul>
    </div>

    <h4>2. Liver</h4>
    <ul>
        <li><strong>Gross:</strong> Enlarged and slate-grey (due to pigment).</li>
        <li><strong>Microscopy:</strong>
            <ul>
                <li><strong>Kupffer Cell Hyperplasia:</strong> Hypertrophied and loaded with black hemozoin pigment.</li>
                <li>Hepatocytes may show fatty change or necrosis (in shock).</li>
            </ul>
        </li>
    </ul>

    <h4>3. Brain (Cerebral Malaria)</h4>
    <ul>
        <li>Caused by <em>P. falciparum</em>.</li>
        <li><strong>Gross:</strong> Brain is edematous. Vessels are congested (cherry-pink color).</li>
        <li><strong>Microscopy:</strong>
            <ul>
                <li>Capillaries are plugged with parasitized RBCs.</li>
                <li><strong>Ring Hemorrhages:</strong> Small petechial hemorrhages around necrotic vessels.</li>
                <li><span class="highlight-neon">Durck’s Granuloma:</span> Areas of necrosis/micro-infarcts surrounded by a glial reaction (microglia).</li>
            </ul>
        </li>
    </ul>

    <h4>4. Kidney (Blackwater Fever)</h4>
    <ul>
        <li>Seen in severe <em>P. falciparum</em> malaria.</li>
        <li><strong>Mechanism:</strong> Massive intravascular hemolysis &rarr; Hemoglobinuria.</li>
        <li><strong>Morphology:</strong> Kidneys are dark brown/black. Tubules are blocked by <strong>Hemoglobin casts</strong>. Features of Acute Tubular Necrosis (ATN) are seen.</li>
    </ul>

    <hr>

    <h2>2. LEPROSY (HANSEN'S DISEASE)</h2>
    
    <p><strong>Definition:</strong> A slowly progressive, chronic granulomatous infectious disease caused by <em>Mycobacterium leprae</em>, primarily affecting the cooler parts of the body: Skin, Peripheral Nerves, Upper Respiratory Tract, Eyes, and Testes.</p>

    <h3>Etiology</h3>
    <ul>
        <li><strong>Agent:</strong> <em>Mycobacterium leprae</em>.
            <ul>
                <li>Acid-fast bacilli (weakly acid-fast compared to TB).</li>
                <li>Obligate intracellular (cannot be grown on artificial media).</li>
                <li>Multiplies best at <span class="highlight-green">32-34°C</span> (hence affects extremities/skin).</li>
            </ul>
        </li>
        <li><strong>Transmission:</strong> Respiratory droplets (nasal secretions) from lepromatous patients. Prolonged skin contact.</li>
        <li><strong>Incubation Period:</strong> Very long (2 to 40 years).</li>
    </ul>

    <h3>Classification</h3>
    <p><strong>Ridley-Jopling Classification (Based on Immunity):</strong></p>
    <ol>
        <li><strong>Tuberculoid (TT):</strong> High Immunity.</li>
        <li><strong>Borderline Tuberculoid (BT)</strong></li>
        <li><strong>Mid-Borderline (BB)</strong></li>
        <li><strong>Borderline Lepromatous (BL)</strong></li>
        <li><strong>Lepromatous (LL):</strong> Low Immunity.</li>
    </ol>
    <p><em>Also: Indeterminate Leprosy (Early stage, not yet classified).</em></p>

    <div class="hand-drawn-box">
        <h3>Pathogenesis (Immunology)</h3>
        <p>The type of leprosy depends on the Host's T-Cell Mediated Immunity (CMI).</p>
        <ul>
            <li><strong>Tuberculoid (TT):</strong> Host has a strong <span class="highlight-neon">Th1 Response</span> (IL-2, IFN-&gamma;).
                <ul>
                    <li>Activates Macrophages &rarr; Kills bacteria &rarr; Forms Epithelioid Granulomas.</li>
                    <li>Localized disease (Paucibacillary).</li>
                </ul>
            </li>
            <li><strong>Lepromatous (LL):</strong> Host has a specific T-cell Anergy (Failure of Th1).
                <ul>
                    <li>Weak CMI. Dominant <span class="highlight-neon">Th2 Response</span> (IL-4, IL-10).</li>
                    <li>B-cells make antibodies (Hypergammaglobulinemia) which are ineffective.</li>
                    <li>Macrophages cannot kill bacteria &rarr; Bacilli multiply unchecked (Multibacillary).</li>
                </ul>
            </li>
        </ul>
    </div>

    <h3>Differences: Tuberculoid vs. Lepromatous Leprosy</h3>

    <table>
        <thead>
            <tr>
                <th>Feature</th>
                <th>Tuberculoid Leprosy (TT)</th>
                <th>Lepromatous Leprosy (LL)</th>
            </tr>
        </thead>
        <tbody>
            <tr>
                <td><strong>Cell Mediated Immunity</strong></td>
                <td><strong>High (Strong Th1)</strong>.</td>
                <td><strong>Absent/Low (Anergy)</strong>.</td>
            </tr>
            <tr>
                <td><strong>Lepromin Test</strong></td>
                <td><span class="highlight-green">Positive</span>.</td>
                <td><span class="highlight-neon">Negative</span>.</td>
            </tr>
            <tr>
                <td><strong>Bacterial Load</strong></td>
                <td>Scanty or Absent (Paucibacillary).</td>
                <td>Numerous (Multibacillary). <strong>Globi</strong> present.</td>
            </tr>
            <tr>
                <td><strong>Skin Lesions</strong></td>
                <td>Few (< 5), asymmetrical. Hypopigmented macular patches with raised margins. Dry and hairless.</td>
                <td>Numerous, symmetrical. Macules, papules, nodules. <span class="highlight-neon">Leonine Facies</span> (Lion-like face) due to skin thickening. Loss of eyebrows (Madarosis).</td>
            </tr>
            <tr>
                <td><strong>Nerve Involvement</strong></td>
                <td>Early, localized, and asymmetrical. Nerves are thickened and palpable (e.g., Ulnar). <strong>Anesthesia</strong> is prominent.</td>
                <td>Late, diffuse, and symmetrical. "Stocking and glove" anesthesia.</td>
            </tr>
            <tr>
                <td><strong>Microscopy (Histology)</strong></td>
                <td>1. <strong>Epithelioid Granulomas</strong> (well-formed).<br>2. Lymphocytic infiltration.<br>3. Granulomas erode the epidermis (No Grenz zone).<br>4. Nerve destruction is severe.</td>
                <td>1. <strong>Virchow Cells</strong> (Foamy histiocytes/macrophages).<br>2. Abundant bacilli in clumps (Globi).<br>3. Clear zone between epidermis and granuloma (<span class="highlight-neon">Grenz Zone</span>).<br>4. Nerves are intact initially.</td>
            </tr>
        </tbody>
    </table>

    <h3>Lepra Reactions</h3>
    <p>Sudden exacerbations of the disease, often after starting treatment.</p>
    <ul>
        <li><strong>Type 1 Reaction (Reversal Reaction):</strong>
            <ul>
                <li>Seen in Borderline cases (BT, BB, BL).</li>
                <li>Due to upgrading of CMI (Type IV Hypersensitivity).</li>
                <li>Existing lesions become red and swollen. Nerves become painful (Neuritis).</li>
            </ul>
        </li>
        <li><strong>Type 2 Reaction (Erythema Nodosum Leprosum - ENL):</strong>
            <ul>
                <li>Seen in Lepromatous cases (BL, LL).</li>
                <li>Due to Antigen-Antibody complex deposition (<span class="highlight-neon">Type III Hypersensitivity</span>).</li>
                <li>Characterized by tender red skin nodules, fever, lymphadenitis, and iridocyclitis.</li>
            </ul>
        </li>
    </ul>

    <hr>

    <h2 style="color: #d32f2f; border-color: #d32f2f;">IMPORTANT UNIVERSITY QUESTIONS</h2>

    <div class="qa-section">
        <h3>Q1: Define Malaria. Describe the Pathogenesis and Pathology of the Spleen and Liver in Malaria.</h3>
        <p><strong>Introduction:</strong> Malaria is a protozoal disease caused by Plasmodium species. It involves a complex interplay between the parasite, RBCs, and the host reticuloendothelial system.</p>
        <p><strong>Body:</strong>
            <br><strong>Pathogenesis:</strong>
            <ul>
                <li><em>Hemolysis:</em> Rupture of parasitized RBCs releases parasite antigens and Hemozoin pigment.</li>
                <li><em>Phagocytosis:</em> The reticuloendothelial cells (macrophages) of the spleen and liver become hyperplastic to clear debris and pigment.</li>
            </ul>
            <br><strong>Pathology of Spleen:</strong>
            <ul>
                <li><em>Gross:</em> In acute cases, it is enlarged, soft, and dark red. In chronic cases ("Ague cake"), it is massive, hard, and slate-grey/black due to fibrosis and heavy pigment.</li>
                <li><em>Microscopy:</em> Sinusoids are congested. Macrophages are laden with malarial pigment. Fibrosis is seen in chronic stages.</li>
            </ul>
            <br><strong>Pathology of Liver:</strong>
            <ul>
                <li><em>Gross:</em> Enlarged and greyish discoloration.</li>
                <li><em>Microscopy:</em> Kupffer cells are enlarged (hyperplastic) and contain black hemozoin pigment. Hepatocytes may show necrosis.</li>
            </ul>
        </p>
        <p><strong>Conclusion:</strong> The slate-grey discoloration of organs due to hemozoin is the hallmark gross feature of malaria.</p>
    </div>

    <div class="qa-section">
        <h3>Q2: Classify Leprosy. Discuss the differences between Tuberculoid and Lepromatous Leprosy in detail.</h3>
        <p><strong>Introduction:</strong> Leprosy is classified based on the Ridley-Jopling scale which reflects the host's cell-mediated immunity (CMI). The spectrum ranges from Tuberculoid (TT) to Lepromatous (LL).</p>
        <p><strong>Body:</strong>
            <br><strong>1. Immunological Basis:</strong>
            <ul>
                <li><em>TT:</em> Strong CMI (Th1 response). Body limits infection. Lepromin positive.</li>
                <li><em>LL:</em> Weak/Absent CMI (Th2 response). Infection disseminates. Lepromin negative.</li>
            </ul>
            <br><strong>2. Clinical Differences:</strong>
            <ul>
                <li><em>TT:</em> Few hypopigmented anesthetic patches. Nerve thickening is early and asymmetrical.</li>
                <li><em>LL:</em> Numerous nodules, Leonine facies, Madarosis. Nerve involvement is late and symmetrical.</li>
            </ul>
            <br><strong>3. Histological Differences:</strong>
            <ul>
                <li><em>TT:</em> Epithelioid granulomas that touch the epidermis. No bacilli found.</li>
                <li><em>LL:</em> Foamy macrophages (Virchow cells) with Globi (bacilli). A clear "Grenz zone" separates the lesion from the epidermis.</li>
            </ul>
        </p>
        <p><strong>Conclusion:</strong> Tuberculoid leprosy represents a contained infection due to good immunity, while Lepromatous leprosy represents disseminated infection due to anergy.</p>
    </div>

</div>

</body>
</html>